|
The information here reflects the current status of the procedure
|
|
|
 |
Identification
Identification procedure
|
 |
|
Reference
|
COD/1999/0180
|
|
|
Title
|
Veterinary medicinal products : Community code (codif. direct. 81/851/EEC, 81/852/EEC, 90/677/EEC, 92/74/EEC)
|
|
Legal Basis
|
EC 095 ; EP 046-p1 |
| Dossier of the committee |
|
|
Subject(s)
|
3.10.08 animal health requirements, veterinary legislation and pharmacy
|
|
Stage reached
|
Procedure ended
|
|
|
Stages
Stages procedure
|
|
|
|
Agents
Agents procedure
|
|
|
European Parliament
|
|
Committee
|
| Rapporteur / Co-rapporteurs |
|
Political group
|
Appointed
|
|
Legal Affairs and Internal Market (responsible)
|
Beysen Ward
|
ELDR
|
21/03/2001
|
|
Environment, Public Health, Consumer Policy (opinion)
|
|
|
|
|
Agriculture and Rural Development (opinion)
|
|
|
|
|
European Commission and Council of the Union
|
| European Commission DG |
Legal Service |
Transmission date: 23/10/2000 |
|
|
|
Internal market
|
meeting: 2371
|
of: 27/09/2001
|
|
|
|
Links to other sources
Links to other sources procedure
|
|
|
|
06/11/2001 - Final legislative act
|
|
PURPOSE : to codify and rationalise the rules on the marketing of veterinary medicinal products.
COMMUNITY MEASURE : Directive 2001/82/EC of the European Parliament and the Council on the Community code relating to veterinary medicinal products.
CONTENT : this Directive codifies and assembles in one text the following directives, which have been frequently and substantially amended: Directives 81/851/EEC, 81/852/EEC, 90/677/EEC, and 92/74/EEC. It also rationalises the marketing of veterinary medicinal products. No such product may be placed on the market of a Member State unless a marketing authorization has been issued in accordance with this directive or been granted in accordance with Regulation 2309/93/EEC. The particulars and documents required to obtain such authorization are set out. There are special provisions relating to homeopathic veterinary medicinal products. Provisions are also made for mutual recognition.
A Committee for Veterinary Medicinal Products is set up, which is part of the European Agency for the Evaluation of Medicinal Products. The Committee will make a scientific evaluation where there is disagreement between Member States about the quality or the safety or the efficacy of a medicinal product. The Directive lays down the circumstances under which marketing authorization must be refused. One such circumstance is where the withdrawal period indicated is not long enough to eliminate health hazards arising from residues. The competent authorities are empowered to prohibit the use of an immunological veterinary medicinal product when the immunological responses of the treated animal will interfere with a national or Community programme for the diagnosis, eradication or control of animal diseases. This Directive does not apply to medicated feedingstuffs.
ENTRY INTO FORCE : 18 December 2001.
|
|
|
List of summaries
List of summaries
|
|
|
13/12/2006
|
Implementing legislative act
|
|
|
11/12/2006
|
Implementing legislative act
|
|
|
06/11/2001
|
Final legislative act
|
|
|
03/07/2001
|
EP: position, 1st reading or single reading
|
|
|
23/10/2000
|
Commission/Council: initial legislative document
|
|
|
08/09/1999
|
Previous initial legislative document
|
|
|
|
